<DOC>
	<DOCNO>NCT00504504</DOCNO>
	<brief_summary>Primary Objective : - To determine feasibility , toxicity , efficacy Rituximab standard dose ABVD combination chemotherapy . ABVD combination chemotherapy consist Adriamycin , Bleomycin , Vinblastine DTIC .</brief_summary>
	<brief_title>Rituximab ABVD Hodgkin 's Patients</brief_title>
	<detailed_description>Before treatment start , patient physical exam . Bone marrow sample take . Blood sample ( 4 8 tablespoon ) take study . A chest x-ray , CT scan abdomen pelvis , gallium scan do necessary . Patients study receive rituximab vein 3 8 hour weekly 6 week row . ABVD inject 3 hour every week total 12 treatment . On cycle rituximab ABVD give , rituximab give day 1 , ABVD give day 2 . Response therapy determine 3 month end therapy ( 6 month ) . At end , patient may receive radiation therapy area large mass . All treatment give outpatient setting . Scans x-ray repeat needed completion therapy every 3 month . If tumor shrink 3 month therapy , patient offer different treatment . This investigational study . Although ABVD consider standard treatment patient Hodgkin 's disease , combination ABVD rituximab consider investigational . All drug involve study commercially available approved FDA . Up 85 patient take part study . All enrol M. D. Anderson . This protocol partially fund research grant Genentech .</detailed_description>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<mesh_term>Bleomycin</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>1 . Hodgkin 's disease patient relapse radiation therapy alone previously untreated patient stage II bulky , III IV eligible ABVD . 2 . Must histologically proven diagnosis Hodgkin 's disease ( Nodular sclerosis mixed cellularity ) . 3 . Must bidimensionally measurable disease . 4 . Must sign consent form . 5 . Must old 16 year age . 6 . Must adequate bone marrow reserve ( ANC &gt; 1,000/microL , Platelet &gt; 100,000/microL 7 . Left Ventricular Ejection Fraction ( LVEF ) &gt; /= 50 % multigated acquisition ( MUGA ) scan echocardiogram . 8 . Serum creatinine &lt; 2 mg/dl , serum bilirubin &lt; 2 mg/dl 1 . HIV positive . 2 . Pregnant woman woman child bear age practice adequate contraception . 3 . Prior chemotherapy . 4 . Severe pulmonary disease include Chronic obstructive pulmonary disease ( COPD ) asthma .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Hodgkin 's Disease</keyword>
	<keyword>Lymphoma</keyword>
	<keyword>Rituximab</keyword>
	<keyword>Rituxan</keyword>
	<keyword>Adriamycin</keyword>
	<keyword>Doxorubicin</keyword>
	<keyword>Rubex</keyword>
	<keyword>Bleomycin</keyword>
	<keyword>Bleomycin sulfate</keyword>
	<keyword>Blenoxane</keyword>
	<keyword>BLM</keyword>
	<keyword>Dacarbazine</keyword>
	<keyword>DTIC</keyword>
	<keyword>DTIC-Dome</keyword>
	<keyword>Vincristine</keyword>
	<keyword>Vinblastine</keyword>
	<keyword>Vinblastine Sulfate</keyword>
	<keyword>ABVD</keyword>
	<keyword>ABVD Chemotherapy Treatment</keyword>
</DOC>